癌症生物学与医学（英文版）2026，Vol.23Issue(6)：946-950,5.DOI:10.20892/j.issn.2095-3941.2025.0848
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma:a retrospective real-world analysis
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma:a retrospective real-world analysis
Yang Liu 1Yong Xu 2Huikai Li 1Chuntao Gao 3Jihui Hao 3Dandan Wu 4Xing Li 2Xihao Zhang 5Rentao Li 5Yanmei Ou 6Hao Wang 4Tongguo Si 7Rui Xia8
作者信息
- 1. Department of Hepatobiliary Cancer,Liver Cancer Center,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Department of Hepatobiliary and Pancreatic Oncology,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 2. Department of Ultrasound Diagnosis and Treatment,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Department of Ultrasound Diagnosis and Treatment,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 3. Department of Hepatobiliary and Pancreatic Oncology,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China||Department of Pancreatic Cancer,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
- 4. Department of Hepatobiliary Cancer,Liver Cancer Center,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
- 5. Department of Hepatobiliary and Pancreatic Oncology,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 6. Department of Ultrasound Diagnosis and Treatment,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 7. Department of Interventional Therapy,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Department of Interventional Therapy,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 8. Intensive Care Unit,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Intensive Care Unit,Tianjin Cancer Hospital Airport Hospital,National Clinical Research Center for Cancer,Tianjin 300308,China
- 折叠
引用本文复制引用
Yang Liu,Yong Xu,Huikai Li,Chuntao Gao,Jihui Hao,Dandan Wu,Xing Li,Xihao Zhang,Rentao Li,Yanmei Ou,Hao Wang,Tongguo Si,Rui Xia..Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma:a retrospective real-world analysis[J].癌症生物学与医学（英文版）,2026,23(6):946-950,5.基金项目
This study received support from Tianjin Health Science and Technology Project(Grant No.TJWJ2022MS007),the Science&Technology Development Fund of Tianjin Education Commission for Higher Education(Grant No.2022ZD067),the Tianjin Municipal Science and Technology Bureau(Grant No.22ZXJBSY00030),the National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine(Grant No.24ZXZSSS00440),and the Independent Project of the Key Laboratory of Drug Efficacy Evaluation and Systematic Translational Medicine,Tianjin Medical University Cancer Institute and Hospital(Grant No.QZ23-11). （Grant No.TJWJ2022MS007）
